周三,Piper Sandler调整了对Robinhood Markets ...
周四,Piper Sandler维持对Robinhood Markets (NASDAQ:HOOD)股票的"增持"评级,目标价保持在$54.00。在Robinhood于纽约市举行首次投资者日活动后,该公司对该股票表现出更为乐观的态度。
Fintel reports that on December 5, 2024, Piper Sandler downgraded their outlook for nCino (NasdaqGS:NCNO) from Overweight to ...
Piper Sandler raised the firm’s price target on Teladoc (TDOC) to $13 from $11 and keeps an Overweight rating on the shares ...
Piper Sandler upgraded Pure Storage (NYSE:PSTG) from Neutral to Overweight following a significant design win with a top-4 ...
Piper Sandler raised the firm’s price target on Okta (OKTA) to $90 from $85 and keeps a Neutral rating on the shares. A ...
智通财经APP获悉,生物制药公司Aclaris Therapeutics (ACRS.US)股价周一上涨53%,至3.14美元,此前该公司宣布获得Biosion独家授权的两种免疫候选药物,这促使Piper Sandler上调了对该公司的评级。
Investing.com -- Investors should temper their expectations regarding the potential accomplishments of the Department of ...
Piper Sandler has initiated coverage of Corbus Pharmaceuticals (CRBP) and Viking Therapeutics (VKTX) with overweight ratings.
Piper Sandler:将CVS Health的目标价从72美元下调至64美元,维持“增持”评级。 (格隆汇) ...
In a report released today, Scott Siefers from Piper Sandler maintained a Sell rating on Huntington Bancshares (HBAN – Research Report), with a ...
A live webcast of the presentation will be available via the Events section of the Company’s investor relations website at https://investors.camp4tx.com/. To request a meeting or for more details ...